Literature DB >> 3525760

Endogenous production of TNF in mice long after BCG sensitization.

M Satoh, H Inagawa, H Minagawa, T Kajikawa, H Oshima, S Abe, M Yamazaki, D Mizuno.   

Abstract

The effect of tuberculin-antigen protein (PPD: purified protein derivatives) on the priming of tumor necrosis factor (TNF) a long time after sensitization with bacillus Calmette-Guérin (BCG) was investigated in mice. Mice were infected intravenously (i.v.) with 4 X 10(7) colony-forming units (CFU) of BCG per mouse, and the TNF activity triggered by 15 micrograms lipopolysaccharide (LPS) was assayed with time using L-929 cells. The activity was maximal 4 weeks after sensitization and decreased to the control level after 10 weeks. The i.v. injection of 10 micrograms of PPD per mouse enhanced the TNF production triggered by LPS in mice even 10-20 weeks after sensitization. This enhancement was unexpectedly quite transient, being maximal 3 h after PPD treatment. The activity was comparable to that in mice 4 weeks after sensitization of BCG (without PPD). The enhancing effect of PPD was observed in the dose range of 0.1-10 micrograms/mouse, and 10 micrograms of PPD significantly enhanced the TNF activity triggered by even 0.6 microgram LPS. These findings indicate that priming of sensitized animals with some antigens followed by triggering with LPS induces a significant endogenous production of TNF even a long time after antigen sensitization. The possible application of these findings for inducing endogenous production of TNF in human patients by use of tuberculin allergy is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3525760

Source DB:  PubMed          Journal:  J Biol Response Mod        ISSN: 0732-6580


  6 in total

1.  Inherent potential for production of tumor necrosis factor-alpha by human intestinal macrophages.

Authors:  Kazue Nakata; Hiroyuki Inagawa; Takashi Nishizawa; Teruko Honda; Chie Kohchi; Yasuhito Tonomoto; Hiroshi Yoshimura; Naofumi Nagasue; Shynji Natori; Hiroshi Terada; Gen-Ichiro Soma
Journal:  Int J Colorectal Dis       Date:  2005-08-10       Impact factor: 2.571

2.  Activation of tumor-infiltrating macrophages by a synthetic lipid A analog (ONO-4007) and its implication in antitumor effects.

Authors:  D Yang; M Satoh; H Ueda; S Tsukagoshi; M Yamazaki
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

3.  Intratumoral induction of tumour necrosis factor by systemic administration of Bordetella pertussis vaccine.

Authors:  H Minagawa; H Kobayashi; H Yoshida; M Teranishi; A Morikawa; S Abe; H Oshima; D I Mizuno
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

4.  Local induction of a cytotoxic factor in a murine tumour by systemic administration of an antitumour polysaccharide, MGA.

Authors:  K Takahashi; Y Watanuki; M Yamazaki; S Abe
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

5.  Endogenous tumor necrosis factor induction with Bordetella pertussis vaccine as a triggering agent and its therapeutic effect on MM46 carcinoma-bearing mice.

Authors:  H Minagawa; Y Kakamu; H Yoshida; F Tomita; H Oshima; D Mizuno
Journal:  Jpn J Cancer Res       Date:  1988-03

6.  A possible role of glucocorticoids: an intrinsic inhibitor of the cytotoxic activity of tumor necrosis factor.

Authors:  S Abe; T Yamamoto; S Iihara; M Yamazaki; D Mizuno
Journal:  Jpn J Cancer Res       Date:  1988-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.